• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative methyltransferase KIAA1456 (KIAA1456)

ACP10513

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10513 Target NameTRMT9B
Target SynonymsTRMT9B; C8orf79; KIAA1456; TRM9L; Probable tRNA methyltransferase 9B; Probable tRNA methyltransferase 9-like protein; EC 2.1.1.-FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-454
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9P272
Background Information
  • Uniprot Id

    Q9P272

  • Target Species

    Human

  • Target Name

    TRMT9B

  • Target Full Name

    Probable tRNA methyltransferase 9B

  • Target Function

    May modifie wobble uridines in specific arginine and glutamic acid tRNAs. Acts as a tumor suppressor by promoting the expression of LIN9.

  • Target Protein Families

    Methyltransferase superfamily

  • Target Tissue Specificity

    Down-regulated in breast, bladder, colorectal, cervix and testicular carcinomas.

  • Target Synonyms

    TRMT9B; C8orf79; KIAA1456; TRM9L; Probable tRNA methyltransferase 9B; Probable tRNA methyltransferase 9-like protein; EC 2.1.1.-

  • Target Background

    Enables tRNA methyltransferase activity. Predicted to be involved in tRNA wobble uridine modification. Predicted to be active in cytoplasm and nucleus.

Inquire Recombinant Human Putative methyltransferase KIAA1456 (KIAA1456) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification